학술논문

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 April 2024, 30(8):1488-1500)
Subject
Language
English
ISSN
15573265
10780432